#USA #Clinical Trials #Columbia #Advarra #eIRB

Advarra Revolutionizes Clinical Trials with Innovative Integration

Advarra, a leader in clinical research technology and regulatory reviews, has unveiled a groundbreaking integration that significantly enhances visibility into the clinical trial site activation process. This new system combines the electronic institutional review board (eIRB) platform, called the Center for IRB Intelligence (CIRBI®), with its Study Collaboration solution, a software designed to streamline site activation and improve enrollment workflow.

The novel integration allows for real-time tracking of site activation milestones and IRB review statuses throughout the clinical trial process. This feature is set to revolutionize how sponsors and clinical research organizations (CROs) manage study startups by providing a centralized dashboard where users can monitor the progression of site activities—from initial site selection to the first patient being enrolled in a study.

With over 14,000 research sites globally already utilizing Advarra's Study Collaboration solution, the integration automates crucial processes such as feasibility assessments, document exchanges, and effective communication, ultimately leading to faster trial initiation. This enhanced visibility minimizes the need for cumbersome manual checks and extensive communications, allowing research teams to focus more on conducting the study effectively.

Ashley Davidson, Vice President and Product Lead for Sponsor Tech Strategy at Advarra, emphasized the significance of this integration, stating, "With our IRB services backing over 60% of clinical trials in North America, we have positioned ourselves uniquely to improve how sponsors and CROs view site activation. By directly embedding IRB status updates into our Study Collaboration tool, we eliminate the reliance on spreadsheets and disparate systems. This empowers study teams with an up-to-the-minute view of every critical step in the enrollment process."

Mark Morais, President and COO of Clinical Development at Fortrea, echoed these sentiments, highlighting that continuous enhancements to the study startup process reduce administrative burdens on sites while offering better insight to sponsors about trial timelines.

As the demand for efficient trial management grows, this integration aligns with the industry's move toward more automated and transparent systems. Clinical trial sponsors can now achieve a comprehensive understanding of site progress without the back-and-forth traditionally entailed in managing trial timelines. The shift towards integrated technologies is becoming increasingly crucial in fostering collaboration between diverse stakeholders involved in clinical research.

To showcase these capabilities, Advarra will host a live demonstration of the latest Study Collaboration solution release on May 8, 2025, allowing interested parties to witness firsthand how these integrated technologies improve operational efficiency and trial visibility. Interested participants can register via Advarra’s website to learn more about this innovative solution.

In summary, Advarra is breaking down barriers that historically impeded the clinical research landscape by merging patients, sites, sponsors, and CROs into a cohesive operational ecosystem. The integration of eIRB systems into their Study Collaboration solution not only accelerates clinical trial timelines but significantly enhances the collaboration, transparency, and speed required to optimize trial operations. This development ensures compliance while simultaneously elevating patient engagement—a win-win for sponsors and trial sites alike.

For more information on how Advarra is reshaping the clinical trial landscape, visit Advarra’s website.